New hope for tough bone cancer: experimental drug takes on chemo
Disease control
Ongoing
This study tests a new drug called HS-20093 against a standard chemotherapy combination (gemcitabine plus docetaxel) in people with osteosarcoma, a type of bone cancer, that has not responded to at least two prior treatments. About 117 participants aged 12 and older will be rando…
Phase: PHASE3 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated May 31, 2026 13:56 UTC